Cargando…

Molecular engineering improves antigen quality and enables integrated manufacturing of a trivalent subunit vaccine candidate for rotavirus

BACKGROUND: Vaccines comprising recombinant subunit proteins are well-suited to low-cost and high-volume production for global use. The design of manufacturing processes to produce subunit vaccines depends, however, on the inherent biophysical traits presented by an individual antigen of interest. N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dalvie, Neil C., Brady, Joseph R., Crowell, Laura E., Tracey, Mary Kate, Biedermann, Andrew M., Kaur, Kawaljit, Hickey, John M., Kristensen, D. Lee, Bonnyman, Alexandra D., Rodriguez-Aponte, Sergio A., Whittaker, Charles A., Bok, Marina, Vega, Celina, Mukhopadhyay, Tarit K., Joshi, Sangeeta B., Volkin, David B., Parreño, Viviana, Love, Kerry R., Love, J. Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088319/ https://www.ncbi.nlm.nih.gov/pubmed/33933073 http://dx.doi.org/10.1186/s12934-021-01583-6

Ejemplares similares

Mechanism of Thimerosal-Induced Structural Destabilization of a Recombinant Rotavirus P[4] Protein Antigen Formulated as a Multi-Dose Vaccine
por: Kaur, Kawaljit, et al.
Publicado: (2021)

Rapid Developability Assessments to Formulate Recombinant Protein Antigens as Stable, Low-Cost, Multi-Dose Vaccine Candidates: Case-Study With Non-Replicating Rotavirus (NRRV) Vaccine Antigens
por: Sawant, Nishant, et al.
Publicado: (2021)

Holistic process development to mitigate proteolysis of a subunit rotavirus vaccine candidate produced in Pichia pastoris by means of an acid pH pulse during fed‐batch fermentation
por: Velez‐Suberbie, M. Lourdes, et al.
Publicado: (2020)

Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens
por: Agarwal, Sanjeev, et al.
Publicado: (2019)

Characterizing and Minimizing Aggregation and Particle Formation of Three Recombinant Fusion-Protein Bulk Antigens for Use in a Candidate Trivalent Rotavirus Vaccine
por: Agarwal, Sanjeev, et al.
Publicado: (2020)

Crystallization of a nonreplicating rotavirus vaccine candidate
por: Hong, Moo Sun, et al.
Publicado: (2021)

Development of a platform process for the production and purification of single‐domain antibodies
por: Crowell, Laura E., et al.
Publicado: (2021)

Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch™ Microprojection Array
por: Wan, Ying, et al.
Publicado: (2018)

Probiotic as Adjuvant Significantly Improves Protection of the Lanzhou Trivalent Rotavirus Vaccine against Heterologous Challenge in a Gnotobiotic Pig Model of Human Rotavirus Infection and Disease
por: Parreno, Viviana, et al.
Publicado: (2022)

Anti-VP6 VHH: An Experimental Treatment for Rotavirus A-Associated Disease
por: Maffey, Lucía, et al.
Publicado: (2016)

Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvants
por: Bajoria, Sakshi, et al.
Publicado: (2022)

Assessment of Influential Factors for Scours Associated with Cryptosporidium sp., Rotavirus and Coronavirus in Calves from Argentinean Dairy Farms
por: Bertoni, Emiliano, et al.
Publicado: (2021)

Comparative genome‐scale analysis of Pichia pastoris variants informs selection of an optimal base strain
por: Brady, Joseph R., et al.
Publicado: (2019)

IgY Antibodies Protect against Human Rotavirus Induced Diarrhea in the Neonatal Gnotobiotic Piglet Disease Model
por: Vega, Celina G., et al.
Publicado: (2012)

Recombinant Monovalent Llama-Derived Antibody Fragments (VHH) to Rotavirus VP6 Protect Neonatal Gnotobiotic Piglets against Human Rotavirus-Induced Diarrhea
por: Vega, Celina G., et al.
Publicado: (2013)

Effect of Aluminum Adjuvant and Preservatives on Structural Integrity and Physicochemical Stability Profiles of Three Recombinant Subunit Rotavirus Vaccine Antigens
por: Agarwal, Sanjeev, et al.
Publicado: (2020)

Combined Live Oral Priming and Intramuscular Boosting Regimen with Rotarix(®) and a Nanoparticle-Based Trivalent Rotavirus Vaccine Evaluated in Gnotobiotic Pig Models of G4P[6] and G1P[8] Human Rotavirus Infection
por: Hensley, Casey, et al.
Publicado: (2023)

Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered Komagataella phaffii
por: Dalvie, Neil C., et al.
Publicado: (2021)

Scalable, methanol‐free manufacturing of the SARS‐CoV‐2 receptor‐binding domain in engineered Komagataella phaffii
por: Dalvie, Neil C., et al.
Publicado: (2021)

Concordance of in vitro and in vivo measures of non-replicating rotavirus vaccine potency
por: McAdams, David, et al.
Publicado: (2022)

Quantification of trivalent non-replicating rotavirus vaccine antigens in the presence of aluminum adjuvant
por: McAdams, David, et al.
Publicado: (2021)

Identifying Improved Sites for Heterologous Gene Integration Using ATAC-seq
por: Brady, Joseph R., et al.
Publicado: (2020)

Simplified Gene Knockout by CRISPR-Cas9-Induced Homologous Recombination
por: Dalvie, Neil C., et al.
Publicado: (2021)

Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamsters
por: Dalvie, Neil C., et al.
Publicado: (2021)

Trivalent Combination Vaccine Induces Broad Heterologous Immune Responses to Norovirus and Rotavirus in Mice
por: Tamminen, Kirsi, et al.
Publicado: (2013)

Egg yolk IgY antibodies: A therapeutic intervention against group A rotavirus in calves
por: Vega, C., et al.
Publicado: (2015)

Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine
por: Lakatos, Kyle, et al.
Publicado: (2020)

A Nanoparticle-Based Trivalent Vaccine Targeting the Glycan Binding VP8* Domains of Rotaviruses
por: Xia, Ming, et al.
Publicado: (2021)

Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice
por: Dalvie, Neil C., et al.
Publicado: (2021)

A New Gnotobiotic Pig Model of P[6] Human Rotavirus Infection and Disease for Preclinical Evaluation of Rotavirus Vaccines
por: Nyblade, Charlotte, et al.
Publicado: (2022)

Steric accessibility of the N-terminus improves the titer and quality of recombinant proteins secreted from Komagataella phaffii
por: Dalvie, Neil C., et al.
Publicado: (2022)

Passive immunity to control Bovine coronavirus diarrhea in a dairy herd in Argentina
por: Bok, Marina, et al.
Publicado: (2018)

Development of an IgY-Based Treatment to Control Bovine Coronavirus Diarrhea in Dairy Calves
por: Bok, Marina, et al.
Publicado: (2023)

Influence of individual or group housing of newborn calves on rotavirus and coronavirus infection during the first 2 months of life
por: Bertoni, E. A., et al.
Publicado: (2021)

Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018(TM) Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD Antigen
por: Bajoria, Sakshi, et al.
Publicado: (2023)

Modular development enables rapid design of media for alternative hosts
por: Biedermann, Andrew M., et al.
Publicado: (2021)

Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants
por: Rodriguez-Aponte, Sergio A., et al.
Publicado: (2023)

A Pseudovirus Nanoparticle-Based Trivalent Rotavirus Vaccine Candidate Elicits High and Cross P Type Immune Response
por: Xia, Ming, et al.
Publicado: (2022)

First report of group A rotavirus and bovine coronavirus associated with neonatal calf diarrhea in the northwest of Argentina
por: Bertoni, E., et al.
Publicado: (2020)

Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine
por: Hamidi, Ahd, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iu4vrt3m93403t7oci6m20mq2t